In PCOS patients, the cumulative LBR tended to be lower in the PPOS group compared to the GnRH antagonist group, although not statistically significant (37.4% vs. 46.1%; P=0.151). The gene discussed is GNRH1; the disease is polycystic ovary syndrome.